Literature DB >> 1906048

The clinical phenotype of two patients with a complete deletion of the iduronate-2-sulphatase gene (mucopolysaccharidosis II--Hunter syndrome).

J E Wraith1, A Cooper, M Thornley, P J Wilson, P V Nelson, C P Morris, J J Hopwood.   

Abstract

Two patients with a complete deletion of the iduronate-2-sulphatase (IDS) gene are described. In both patients, the resulting phenotype was that of very severe Hunter syndrome (mucopolysaccharidosis II). In addition, both had features not commonly seen in this disorder, e.g. early onset of seizures in one patient and ptosis in the other. It is speculated that loss of adjacent loci may contribute to the unusual findings and that the severe features present in both patients may represent contiguous gene syndromes. Further analysis of IDS cDNA from other patients with Hunter's syndrome may eventually enable phenotype to be predicted more accurately.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906048     DOI: 10.1007/bf00204183

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  10 in total

Review 1.  The mucopolysaccharidoses. Diagnosis, molecular genetics and treatment.

Authors:  J J Hopwood; C P Morris
Journal:  Mol Biol Med       Date:  1990-10

Review 2.  Contiguous gene syndromes: a component of recognizable syndromes.

Authors:  R D Schmickel
Journal:  J Pediatr       Date:  1986-08       Impact factor: 4.406

3.  Genetic mapping of new RFLPs at Xq27-q28.

Authors:  G K Suthers; I Oberlé; J Nancarrow; J C Mulley; V J Hyland; P J Wilson; J McCure; C P Morris; J J Hopwood; J L Mandel
Journal:  Genomics       Date:  1991-01       Impact factor: 5.736

4.  High-resolution electrophoresis of urinary glycosaminoglycans: an improved screening test for the mucopolysaccharidoses.

Authors:  J J Hopwood; J R Harrison
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

5.  An assay for iduronate sulfatase (Hunter corrective factor).

Authors:  T W Lim; I G Leder; G Bach; E F Neufeld
Journal:  Carbohydr Res       Date:  1974-10       Impact factor: 2.104

6.  alpha-L-iduronidase, beta-D-glucuronidase, and 2-sulfo-L-iduronate 2-sulfatase: preparation and characterization of radioactive substrates from heparin.

Authors:  J J Hopwood
Journal:  Carbohydr Res       Date:  1979-03       Impact factor: 2.104

7.  Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA.

Authors:  P J Wilson; C P Morris; D S Anson; T Occhiodoro; J Bielicki; P R Clements; J J Hopwood
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

8.  Cystic fibrosis: prenatal diagnosis and carrier detection by DNA analysis.

Authors:  P V Nelson; W F Carey; C P Morris; A C Pollard
Journal:  Med J Aust       Date:  1989-08-07       Impact factor: 7.738

9.  Frequent deletions at Xq28 indicate genetic heterogeneity in Hunter syndrome.

Authors:  P J Wilson; G K Suthers; D F Callen; E Baker; P V Nelson; A Cooper; J E Wraith; G R Sutherland; C P Morris; J J Hopwood
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

10.  Chromosomal localization of the gene for human glucosamine-6-sulphatase to 12q14.

Authors:  D A Robertson; D F Callen; E G Baker; C P Morris; J J Hopwood
Journal:  Hum Genet       Date:  1988-06       Impact factor: 4.132

  10 in total
  7 in total

1.  Gene diagnosis and carrier detection in Hunter syndrome by the iduronate-2-sulphatase cDNA probe.

Authors:  A Gal; M Beck; A C Sewell; C P Morris; E Schwinger; J J Hopwood
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Structural gene aberrations in mucopolysaccharidosis II (Hunter).

Authors:  M Wehnert; J J Hopwood; W Schröder; F H Herrmann
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

3.  Hyposulfatemia, growth retardation, reduced fertility, and seizures in mice lacking a functional NaSi-1 gene.

Authors:  Paul A Dawson; Laurent Beck; Daniel Markovich
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-24       Impact factor: 11.205

4.  Mutation analysis in 57 unrelated patients with MPS II (Hunter's disease).

Authors:  E Vafiadaki; A Cooper; L E Heptinstall; C E Hatton; M Thornley; J E Wraith
Journal:  Arch Dis Child       Date:  1998-09       Impact factor: 3.791

Review 5.  Neurological findings in Hunter disease: pathology and possible therapeutic effects reviewed.

Authors:  S Al Sawaf; E Mayatepek; B Hoffmann
Journal:  J Inherit Metab Dis       Date:  2008-07-13       Impact factor: 4.982

6.  Molecular diagnosis of mucopolysaccharidosis type II (Hunter syndrome) by automated sequencing and computer-assisted interpretation: toward mutation mapping of the iduronate-2-sulfatase gene.

Authors:  J J Jonsson; E L Aronovich; S E Braun; C B Whitley
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

Review 7.  Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.

Authors:  J Edmond Wraith; Maurizio Scarpa; Michael Beck; Olaf A Bodamer; Linda De Meirleir; Nathalie Guffon; Allan Meldgaard Lund; Gunilla Malm; Ans T Van der Ploeg; Jiri Zeman
Journal:  Eur J Pediatr       Date:  2007-11-23       Impact factor: 3.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.